You searched for asthma

Drugs in the Pipeline

Ensifentrine Improves Lung Function, Cuts COPD Exacerbations in Late Stage Trial

August 9, 2022

Ensifentrine (RPL554) is a first-in-class, dual phosphodiesterase (PDE) 3 and 4 inhibitor with combined bronchodilator and anti-inflammatory actions.

News

Enhertu Approved for HER2-Low Metastatic Breast Cancer

August 8, 2022

The approval was based on data from a phase 3 trial that included adults with unresectable or metastatic HER2-low breast cancer who had previous lines of chemotherapy.

News

New Tablet Formulation of Calquence Approved for CLL, SLL, MCL

August 5, 2022

The approval was based on data from the phase 1 ELEVATE-PLUS trials, which showed the acalabrutinib 100mg tablets were bioequivalent to the acalabrutinib 100mg capsules.

Drugs in the Pipeline

Enhertu Gets Priority Review for HER2-Low Metastatic Breast Cancer

July 25, 2022

The sBLA is supported by data from the phase 3 DESTINY-Breast04 trials.

News

OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained

July 25, 2022

Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab

News

Rosuvastatin Increases Risk of Hematuria, Proteinuria

July 25, 2022

Few real-world studies have investigated the risks of hematuria and proteinuria associated with rosuvastatin use.

News

Hypertension Ups Odds of Omicron-Variant COVID-19 Hospitalization

July 22, 2022

Observational study findings highlight a "persistent and marked" association between hypertension and risk for severe COVID-19, even among fully vaccinated patients, according to investigators.

News

Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment

July 15, 2022

Finding from a nationwide study of 5,000 participants that continues to evaluate existing drugs to treat mild-to-moderate COVID-19

Drugs in the Pipeline

Dupilumab Demonstrates Benefit in Pediatric Eosinophilic Esophagitis Trial

July 14, 2022

The phase 3 EoE KIDS study included 102 children with active eosinophilic esophagitis based on histologic improvement meeting validated histologic criteria.

News

Azithromycin Improves Outcomes in Poorly Controlled Child Asthma

June 21, 2022

Better control, fewer exacerbations seen with addition of oral azithromycin to standard therapy in children with poorly controlled asthma

Active Filters

Your search for asthma returned 1798 results

Sort Results:

Ensifentrine Improves Lung Function, Cuts COPD Exacerbations in Late Stage Trial

Enhertu Approved for HER2-Low Metastatic Breast Cancer

New Tablet Formulation of Calquence Approved for CLL, SLL, MCL

Enhertu Gets Priority Review for HER2-Low Metastatic Breast Cancer

OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained

Rosuvastatin Increases Risk of Hematuria, Proteinuria

Hypertension Ups Odds of Omicron-Variant COVID-19 Hospitalization

Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment

Dupilumab Demonstrates Benefit in Pediatric Eosinophilic Esophagitis Trial

Azithromycin Improves Outcomes in Poorly Controlled Child Asthma